PETER WIRTH Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PETER WIRTH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PETER WIRTH. PETER WIRTH is Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and Director in Forma Therapeutics Holdings, Inc., ($FMTX) and Director in Syros Pharmaceuticals, Inc. ($SYRS) and Director in Zai Lab Ltd ($ZLAB).
Latest Insider Trading Transactions of PETER WIRTH
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, FMTX, GEVA, SYRS, ZLAB
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 21 2021 | FMTX | Forma Therapeutics ... | WIRTH PETER | Director | Option Exercise | A | 25.35 | 8,375 | 212,306 | 8,375 | |
| Jun 21 2021 | FMTX | Forma Therapeutics ... | WIRTH PETER | Director | Grant | A | 0.00 | 2,750 | 0 | 130,415 | 127.7 K to 130.4 K (+2.15 %) |
| Jan 20 2021 | ZLAB | Zai Lab Ltd | WIRTH PETER | Director | Grant | A | 0.00 | 3,852 | 0 | 338,852 | 335 K to 338.9 K (+1.15 %) |
| Jun 24 2020 | FMTX | Forma Therapeutics ... | WIRTH PETER | Director | Sell | S | 0.00 | 14,026 | 0 | 0 | 14 K to 0 (-100.00 %) |
| Jun 24 2020 | FMTX | Forma Therapeutics ... | WIRTH PETER | Director | Sell | S | 0.00 | 10,240 | 0 | 0 | 10.2 K to 0 (-100.00 %) |
| Jun 24 2020 | FMTX | Forma Therapeutics ... | WIRTH PETER | Director | Sell | S | 0.00 | 9,847 | 0 | 0 | 9.8 K to 0 (-100.00 %) |
| Jun 24 2020 | FMTX | Forma Therapeutics ... | WIRTH PETER | Director | Sell | S | 0.00 | 18,585 | 0 | 0 | 18.6 K to 0 (-100.00 %) |
| Jun 24 2020 | FMTX | Forma Therapeutics ... | WIRTH PETER | Director | Sell | S | 0.00 | 25,756 | 0 | 0 | 25.8 K to 0 (-100.00 %) |
| Jun 24 2020 | FMTX | Forma Therapeutics ... | WIRTH PETER | Director | Buy | P | 0.00 | 63,299 | 0 | 127,665 | 64.4 K to 127.7 K (+98.34 %) |
| Jun 24 2020 | FMTX | Forma Therapeutics ... | WIRTH PETER | Director | Sell | S | 0.00 | 14,026 | 0 | 0 | 14 K to 0 (-100.00 %) |
| Jun 24 2020 | FMTX | Forma Therapeutics ... | WIRTH PETER | Director | Sell | S | 0.00 | 10,240 | 0 | 0 | 10.2 K to 0 (-100.00 %) |
| Jun 24 2020 | FMTX | Forma Therapeutics ... | WIRTH PETER | Director | Sell | S | 0.00 | 9,847 | 0 | 0 | 9.8 K to 0 (-100.00 %) |
| Jun 24 2020 | FMTX | Forma Therapeutics ... | WIRTH PETER | Director | Sell | S | 0.00 | 18,585 | 0 | 0 | 18.6 K to 0 (-100.00 %) |
| Jun 24 2020 | FMTX | Forma Therapeutics ... | WIRTH PETER | Director | Sell | S | 0.00 | 25,756 | 0 | 0 | 25.8 K to 0 (-100.00 %) |
| Jun 24 2020 | FMTX | Forma Therapeutics ... | WIRTH PETER | Director | Buy | P | 0.00 | 63,299 | 0 | 127,665 | 64.4 K to 127.7 K (+98.34 %) |
| Jun 22 2020 | FMTX | Forma Therapeutics ... | WIRTH PETER | Director | Option Exercise | A | 20.00 | 17,533 | 350,660 | 0 | |
| Jun 11 2020 | SYRS | Syros Pharmaceutic ... | WIRTH PETER | Director | Option Exercise | A | 9.17 | 17,500 | 160,475 | 17,500 | |
| Jun 11 2020 | SYRS | Syros Pharmaceutic ... | WIRTH PETER | Director | Option Exercise | A | 9.17 | 17,500 | 160,475 | 17,500 | |
| Jun 12 2019 | SYRS | Syros Pharmaceutic ... | WIRTH PETER | Director | Option Exercise | A | 5.60 | 11,000 | 61,600 | 11,000 | |
| Jun 15 2018 | SYRS | Syros Pharmaceutic ... | WIRTH PETER | Director | Option Exercise | A | 12.95 | 11,000 | 142,450 | 11,000 | |
| Jan 30 2017 | SYRS | Syros Pharmaceutic ... | WIRTH PETER | Director | Option Exercise | A | 10.76 | 22,000 | 236,720 | 22,000 | |
| Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | WIRTH PETER | Director | Option Exercise | D | 80.35 | 7,500 | 602,625 | 0 | |
| Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | WIRTH PETER | Director | Option Exercise | D | 40.74 | 15,000 | 611,100 | 0 | |
| Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | WIRTH PETER | Director | Option Exercise | D | 40.32 | 7,500 | 302,400 | 0 |
Page: 1